AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that it has received confirmation that its Prospera Lung donor-derived ...

Innovations in technology have enabled the creation of point-of-care ultrasound, which allows clinicians to gather images at the first patient assessment, improving care quality by reducing wait times ...

Non-invasive genomic test is designed to help physicians guide next steps for current and former smokers with lung nodules Lung cancer is the leading cause of cancer death worldwide. Lung nodules are ...

Meta-analysis links prior tuberculosis and chronic bronchitis to higher lung cancer risk in never-smokers, with implications ...

Chronic lung disease and socioeconomic factors were independently linked to higher lung cancer risk in never-smokers, highlighting the need for multifactorial risk assessment beyond smoking history.

The California Technology Assessment Forum is requested to review the scientific evidence for the use of low dose spiral computerized tomography (LDCT) as a modality for lung cancer screening. This is ...

Minna Purokivi was appointed as Professor of Respiratory Medicine at the University of Eastern Finland this January. Her research group focuses, in particular, on interstitial lung diseases (ILD), ...